Completed
Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
NCT01766817
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States